Kinetic intermediates of unfolding of dimeric prostatic phosphatase

• Authors: Radosława Kuciel , Aleksandra Mazurkiewicz , Paulina Dudzik
• Languages of publication: EN

Abstracts

EN

Kinetics of guanidine hydrochloride (GdnHCl)-induced unfolding of human prostatic acid phosphatase (hPAP), a homodimer of 50 kDa subunit molecular mass was investigated with enzyme activity measurements, capacity for binding an external hydrophobic probe, 1-anilinonaphtalene-8-sulfonate (ANS), accessibility of thiols to reaction with 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) and 2-(4'-maleimidylanilino)naphthalene-6-sulfonate (MIANS) and ability to bind Congo red dye. Kinetic analysis was performed to describe a possible mechanism of hPAP unfolding and dissociation that leads to generation of an inactive monomeric intermediate that resembles, in solution of 1.25 M GdnHCl pH 7.5, at 20°C, in equilibrium, a molten globule state. The reaction of hPAP inactivation in 1.25 M GdnHCl followed first order kinetics with the reaction rate constant 0.0715 ± 0.0024 min-1 . The rate constants of similar range were found for the pseudo-first-order reactions of ANS and Congo red binding: 0.0366 ± 0.0018 min-1 and 0.0409 ± 0.0052 min-1, respectively. Free thiol groups, inaccessible in the native protein, were gradually becoming, with the progress of unfolding, exposed for the reactions with DTNB and MIANS, with the pseudo-first-order reaction rate constants 0.327 ± 0.014 min-1 and 0.216 ± 0.010 min-1, respectively. The data indicated that in the course of hPAP denaturation exposure of thiol groups to reagents took place faster than the enzyme inactivation and exposure of the protein hydrophobic surface. This suggested the existence of a catalytically active, partially unfolded, but probably dimeric kinetic intermediate in the process of hPAP unfolding. On the other hand, the protein inactivation was accompanied by exposure of a hydrophobic, ANS-binding surface, and with an increased capacity to bind Congo red. Together with previous studies these results suggest that the stability of the catalytically active conformation of the enzyme depends mainly on the dimeric structure of the native hPAP.

Keywords

EN

dimer; prostatic phosphatase; protein unfolding

• Publisher: Polish Biochemical Society
• Journal: Acta Biochimica Polonica
• Year: 2007
• Volume: 54
• Issue: 2
• Pages: 371-377

Dates

published

2007

received

2006-11-11

revised

2007-03-17

accepted

2007-04-17

(unknown)

2007-05-23

Contributors

author

Radosława Kuciel

• Chair of Medical Biochemistry, Collegium Medicum, Jagiellonian University, Kraków, Poland

author

Aleksandra Mazurkiewicz

• Chair of Medical Biochemistry, Collegium Medicum, Jagiellonian University, Kraków, Poland

author

Paulina Dudzik

• Chair of Medical Biochemistry, Collegium Medicum, Jagiellonian University, Kraków, Poland

References

• Bardsley WG (2005) SIMFIT a package for simulation, curve fitting, graph plotting and statistical analysis. University of Manchester, UK.
• Bobrzecka K, Ostrowski W, Rybarska J (1968) The effect of iodination on the activity and structure of acid phosphomonoesterase from human prostate. Acta Biochim Polon 15: 369-379.
• Couthon F, Clottes E, Ebel Ch, Vial Ch (1995) Reversible dissociation and unfolding of dimeric creatine kinase isoenzyme MM in guanidine hydrochloride and urea. Eur J Biochem 234: 160-170.
• Jakob CG, Lewiński K, Kuciel R, Ostrowski W, Lebioda L (2000) Crystal structure of human prostatic acid phosphatase. Prostate 42: 211-218.
• Kuciel R, Mazurkiewicz A (1997) Molten globule as an intermediate on the human prostatic phosphatase folding pathway. Acta Biochim Polon 44: 645-658.
• Kuciel R, Bakalova A, Mazurkiewicz A, Bilska A, Ostrowski W (1990) Is the subunit of prostatic phosphatase active? Reversible denaturation of prostatic acid phosphatase. Biochem Int 22: 329-334.
• Kuciel R, Mazurkiewicz A, Ostrowski WS (1996) The folding intermediate of reversibly denatured human prostatic acid phosphatase. Int J Biol Macromol 18: 167-175.
• Kuwajima K (1989) The molten globule state as a clue for understanding the folding and cooperativity of globular-protein structure. Proteins 6: 87-103.
• LaCount MW, Handy G, Lebioda L (1998) Structural origins of l(+)-tartrate inhibition of human prostatic acid phosphatase. J Biol Chem 273: 30406-30409.
• Lindquist Y, Schneider G, Vihko P (1994) Crystal structures of rat acid phosphatase complexed with the transition-state analogs vanadate and molybdate. Implications for the reaction mechanism. Eur J Biochem 221: 139-142.
• Luchter-Wasyl E, Ostrowski WS (1974) Subunit structure of human prostatic acid phosphatase. Biochim Biophys Acta 365: 349-359.
• Ortlund E, LaCount MW, Lebioda L (2003) Crystal structures of human prostatic acid phosphatase in complex with a phosphate ion and alpha-benzylaminobenzylphosphonic acid update the mechanistic picture and offer new insights into inhibitor design. Biochemistry 42: 383-389.
• Ostanin K, Saeed A, Van Etten RL (1994) Heterologous expression of human prostatic acid phosphatase and site-directed mutagenesis of the enzyme active site. J Biol Chem 269: 8971-8978.
• Ostrowski WS, Kuciel R, Tanaka F, Yagi K (1993) Fluorometric analysis of native, urea-denatured and refolded human prostatic acid phosphatase. Biochim Biophys Acta 1164: 319-326.
• Ou W-B, Park Y-D, Zhou H-M (2002) Effect of osmolytes as folding aids on creatine kinase refolding pathway. Int J Biochem Cell Biol 34: 136-147.
• Piekarska B, Roterman I, Rybarska J, Konieczny L, Kaszuba J (1994) The melting of native domain structure in effector activation of IgG studied by using Congo red as a specific probe. J Physiol Pharmacol 45: 147-162.
• Piekarska B, Skowronek M, Rybarska J, Stopa B, Roterman I, Konieczny L (1996), Congo red-stabilized intermediates in the lambda light chain transition from native to molten state. Biochimie 78: 183-189.
• Porvari KS, Herrala AM, Kurkela RM, Taavitsainen PA, Lindquist Y, Schneider G, Vihko PT (1994) Site-directed mutagenesis of prostatic acid phosphatase. Catalytically important aspartic acid 258, substrate specificity, and oligomerization. J Biol Chem 269: 22642-22646.
• Ptitsyn OB (1994) Kinetic and equilibrium intermediates in protein folding. Protein Eng 7: 593-596.
• Reyes AM, Ludwig HC, Yanez AJ, Rodriquez PH, Slebe JC (2003) Nativelike intermediate on the unfolding pathway of pig kidney fructose-1,6-bisphosphatase. Biochemistry 42: 6956-6964.
• Riddles PW, Blakeley RL, Zerner B (1979) Ellman's reagent; 5,5'-dithiobis(2-nitrobenzoic acid) - a reexamination. Anal Biochem 94: 75-81.
• Schliebs W, Thanki N, Jaenicke R, Wierenga RK (1997) A double mutation at the tip of the dimer interface loop of triosephosphate isomerase generates active monomers with reduced stability. Biochemistry 36: 9655-9662.
• Schneider G, Lindquist Y, Vihko P (1993) Three-dimensional structure of rat acid phosphatase. EMBO J 12: 2609-2615.
• Van Etten R, Saini MS (1978) Selective purification of tartrate-inhibitable acid phosphatases: rapid and efficient purification (to homogeneity) of human and canine prostatic acid phosphatases. Clin Chem 24: 1525-1530.
• Van Etten RL, Davidson R, Stevis PE, MacArthur H, Moore LJ (1991) Covalent structure, disulfide bonding, and identification of reactive surface and active site residues of human prostatic acid phosphatase. J Biol Chem 266: 2313-2319.
• Wójciak P, Mazurkiewicz A, Bakalova A, Kuciel R (2003) Equilibrium unfolding of dimeric human prostatic acid phosphatase involves an inactive monomeric intermediate. Int J Biol Macromol 32: 43-54.